SG70589A1 - 1, 25-Dihydroxy-16, 22, 23-trisdehydro-cholecalciferol derivatives - Google Patents

1, 25-Dihydroxy-16, 22, 23-trisdehydro-cholecalciferol derivatives

Info

Publication number
SG70589A1
SG70589A1 SG1997000771A SG1997000771A SG70589A1 SG 70589 A1 SG70589 A1 SG 70589A1 SG 1997000771 A SG1997000771 A SG 1997000771A SG 1997000771 A SG1997000771 A SG 1997000771A SG 70589 A1 SG70589 A1 SG 70589A1
Authority
SG
Singapore
Prior art keywords
trisdehydro
dihydroxy
cholecalciferol derivatives
cholecalciferol
derivatives
Prior art date
Application number
SG1997000771A
Other languages
English (en)
Inventor
Bernard Michael Hennessy
Jerome Anthony Iacobelli
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SG70589A1 publication Critical patent/SG70589A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Furan Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG1997000771A 1996-03-21 1997-03-11 1, 25-Dihydroxy-16, 22, 23-trisdehydro-cholecalciferol derivatives SG70589A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1380996P 1996-03-21 1996-03-21

Publications (1)

Publication Number Publication Date
SG70589A1 true SG70589A1 (en) 2000-02-22

Family

ID=21761865

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1997000771A SG70589A1 (en) 1996-03-21 1997-03-11 1, 25-Dihydroxy-16, 22, 23-trisdehydro-cholecalciferol derivatives

Country Status (30)

Country Link
EP (1) EP0796843B1 (xx)
JP (1) JP2801587B2 (xx)
KR (1) KR100240541B1 (xx)
CN (1) CN1110477C (xx)
AR (1) AR006315A1 (xx)
AT (1) ATE240941T1 (xx)
AU (1) AU708679B2 (xx)
BR (1) BR9701404A (xx)
CA (1) CA2199893C (xx)
CO (1) CO4820396A1 (xx)
CZ (1) CZ85897A3 (xx)
DE (1) DE69722064T2 (xx)
DK (1) DK0796843T3 (xx)
ES (1) ES2198512T3 (xx)
HR (1) HRP970162A2 (xx)
HU (1) HUP9700609A3 (xx)
ID (1) ID16285A (xx)
IL (1) IL120469A0 (xx)
MA (1) MA26423A1 (xx)
MX (1) MX9702139A (xx)
NO (1) NO971217L (xx)
NZ (1) NZ314424A (xx)
PE (1) PE42998A1 (xx)
PL (1) PL319070A1 (xx)
PT (1) PT796843E (xx)
SG (1) SG70589A1 (xx)
TR (1) TR199700219A2 (xx)
TW (1) TW444001B (xx)
YU (1) YU10397A (xx)
ZA (1) ZA972302B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9625271D0 (en) * 1996-12-04 1997-01-22 Leo Pharm Prod Ltd Chemical compounds
US6331642B1 (en) * 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs
KR101285720B1 (ko) * 2012-03-02 2013-07-19 주식회사 유니크메디케어 여드름 개선용 조성물
KR102493627B1 (ko) 2015-11-26 2023-01-31 코웨이 주식회사 호르데닌을 유효성분으로 함유하는 피부암 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
EP0398217B1 (de) * 1989-05-18 1994-01-12 F. Hoffmann-La Roche Ag Dehydrocholecalciferolderivate

Also Published As

Publication number Publication date
AU708679B2 (en) 1999-08-12
MX9702139A (es) 1998-04-30
JPH107651A (ja) 1998-01-13
ZA972302B (en) 1997-09-22
NO971217D0 (no) 1997-03-17
IL120469A0 (en) 1997-07-13
PE42998A1 (es) 1998-08-11
ES2198512T3 (es) 2004-02-01
CN1172793A (zh) 1998-02-11
YU10397A (sh) 1999-07-28
CA2199893A1 (en) 1997-09-21
CO4820396A1 (es) 1999-07-28
NO971217L (no) 1997-09-22
DE69722064D1 (de) 2003-06-26
HRP970162A2 (en) 1998-04-30
HU9700609D0 (en) 1997-05-28
HUP9700609A2 (hu) 1998-07-28
BR9701404A (pt) 1998-11-03
TW444001B (en) 2001-07-01
EP0796843B1 (en) 2003-05-21
DE69722064T2 (de) 2004-04-08
KR100240541B1 (ko) 2000-01-15
TR199700219A3 (tr) 1997-10-21
ID16285A (id) 1997-09-18
MA26423A1 (fr) 2004-12-20
DK0796843T3 (da) 2003-09-15
NZ314424A (en) 1998-07-28
PL319070A1 (en) 1997-09-29
TR199700219A2 (xx) 1997-10-21
KR970065495A (ko) 1997-10-13
AU1513597A (en) 1997-09-25
AR006315A1 (es) 1999-08-25
PT796843E (pt) 2003-09-30
JP2801587B2 (ja) 1998-09-21
CN1110477C (zh) 2003-06-04
EP0796843A3 (en) 1999-04-14
EP0796843A2 (en) 1997-09-24
CZ85897A3 (cs) 1998-04-15
CA2199893C (en) 2008-02-05
HUP9700609A3 (en) 1999-03-01
ATE240941T1 (de) 2003-06-15

Similar Documents

Publication Publication Date Title
HRP970454B1 (en) Substituted 6,5-hetero-bicyclic derivatives
HK1019597A1 (en) Substituted 6, 6-hetero-bicyclic derivatives
GB2319250B (en) Derivatives of 6,8-Difluoro-7-Hydroxycoumarin
IL141908A0 (en) 1,4-benzodiazepine derivatives
PL331602A1 (en) Pyrido- or pyrimido-substituted 6,6- or 6,7-bicyclic derivatives
HK1018216A1 (en) New 19-nor-pregnene derivatives.
AP9701156A0 (en) 6-phenylpyridyl-2-amine derivatives
IL145681A0 (en) Substituted 1,2,3,4-tetrahydronaphthalene derivatives
HK1018457A1 (en) Alkylaminobenzothiazole and-benzoxazole derivatives.
IL126624A0 (en) 3-descladinose-2, 3-anhydroerythromycin derivatives
HU9802807D0 (en) 1,3,8-triazo-spiro[4,5]decan-4-on derivatives
HRP970260A2 (en) 2,4-diaminopyrimidine derivatives
AP9500731A0 (en) 1,5 benzodiazepine derivatives
GB2311779B (en) 2,3 benzodiazepine derivatives
ZA974953B (en) Substituted pyrazolylpyrazole derivatives.
CY2322B1 (en) Benzoaeguequinoline derivatives.
ZA971167B (en) Heterocyclyl-ergoline derivatives.
SG70589A1 (en) 1, 25-Dihydroxy-16, 22, 23-trisdehydro-cholecalciferol derivatives
IL132162A (en) 2,3-epoxypropionamide derivatives
IL132162A0 (en) 2, 3-Epoxypropionamide derivatives
HUP9903369A3 (en) 8(9)-dehydroestradiol derivatives
ZA977881B (en) N-benzylazolium derivatives.
ZA972692B (en) Pyrrolopyrrolone derivatives.
ZA965384B (en) 4-Amino-5-oxy-2,6,6-trimethyl-2-cycloheptene compounds
ZA953056B (en) 1,5 benzodiazepine derivatives